These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 24315012)
21. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [TBL] [Abstract][Full Text] [Related]
22. Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor. Ringdén O; Okas M; Uhlin M; Uzunel M; Remberger M; Mattsson J Bone Marrow Transplant; 2008 Nov; 42(10):643-8. PubMed ID: 18762760 [TBL] [Abstract][Full Text] [Related]
23. Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium. Yu LC; Wall DA; Sandler E; Chan KW; Grayson G; Kletzel M Pediatr Hematol Oncol; 2001 Jun; 18(4):235-45. PubMed ID: 11400647 [TBL] [Abstract][Full Text] [Related]
24. Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: a report from the Australian and New Zealand children's haematology and oncology group. Petterson TE; Gabriel M; Tiedemann K; Teague L; Shaw PJ; Baker D; Bolton-Jones R; Tapp H; Oswald C; Vowels MR; O'Brien TA Bone Marrow Transplant; 2009 Feb; 43(3):207-15. PubMed ID: 18806837 [TBL] [Abstract][Full Text] [Related]
25. Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors. Lazaryan A; Weisdorf DJ; DeFor T; Brunstein CG; MacMillan ML; Bejanyan N; Holtan S; Blazar BR; Wagner JE; Arora M Biol Blood Marrow Transplant; 2016 Jan; 22(1):134-40. PubMed ID: 26365153 [TBL] [Abstract][Full Text] [Related]
26. Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch. Slack JL; Dueck AC; Fauble VD; Sproat LO; Reeder CB; Noel P; Khera N; Betcher JA; Klein JL; Leis JF; Adams RH Biol Blood Marrow Transplant; 2013 Aug; 19(8):1167-74. PubMed ID: 23664940 [TBL] [Abstract][Full Text] [Related]
27. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. Rocha V; Labopin M; Sanz G; Arcese W; Schwerdtfeger R; Bosi A; Jacobsen N; Ruutu T; de Lima M; Finke J; Frassoni F; Gluckman E; ; N Engl J Med; 2004 Nov; 351(22):2276-85. PubMed ID: 15564544 [TBL] [Abstract][Full Text] [Related]
28. Admission of hematopoietic cell transplantation patients to the intensive care unit at the Pontificia Universidad Católica de Chile Hospital. Escobar K; Rojas P; Ernst D; Bertin P; Nervi B; Jara V; Garcia MJ; Ocqueteau M; Sarmiento M; Ramirez P Biol Blood Marrow Transplant; 2015 Jan; 21(1):176-9. PubMed ID: 25139214 [TBL] [Abstract][Full Text] [Related]
29. Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre. Bradstock KF; Hertzberg MS; Kerridge IH; Svennilson J; McGurgan M; Huang G; Antonenas V; Gottlieb DJ Intern Med J; 2006 Jun; 36(6):355-61. PubMed ID: 16732860 [TBL] [Abstract][Full Text] [Related]
30. Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant. Martino R; Caballero MD; de la Serna J; Díez-Martín JL; Urbano-Ispízua A; Tomás JF; Odriozola J; León A; Canals C; San Miguel J; Sierra J Bone Marrow Transplant; 2002 Jul; 30(2):63-8. PubMed ID: 12132043 [TBL] [Abstract][Full Text] [Related]
31. Effect of graft source on mismatched unrelated donor hemopoietic stem cell transplantation after reduced intensity conditioning. Malard F; Fürst S; Loirat M; Chevallier P; El-Cheikh J; Guillaume T; Delaunay J; Le Gouill S; Moreau P; Blaise D; Mohty M Leukemia; 2013 Nov; 27(11):2113-7. PubMed ID: 23752174 [TBL] [Abstract][Full Text] [Related]
32. A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy. Shore T; Harpel J; Schuster MW; Roboz GJ; Leonard JP; Coleman M; Feldman EJ; Silver RT Biol Blood Marrow Transplant; 2006 Aug; 12(8):868-75. PubMed ID: 16864057 [TBL] [Abstract][Full Text] [Related]
35. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
36. Dendritic cell count in the graft predicts relapse in patients with hematologic malignancies undergoing an HLA-matched related allogeneic peripheral blood stem cell transplant. Rajasekar R; Lakshmi KM; George B; Viswabandya A; Thirugnanam R; Abraham A; Chandy M; Srivastava A; Mathews V Biol Blood Marrow Transplant; 2010 Jun; 16(6):854-60. PubMed ID: 20138229 [TBL] [Abstract][Full Text] [Related]
37. Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients. Satwani P; Jin Z; Duffy D; Morris E; Bhatia M; Garvin JH; George D; Bradley MB; Harrison L; Petrillo K; Schwartz J; Foley S; Hawks R; Baxter-Lowe LA; Cairo MS Biol Blood Marrow Transplant; 2013 Apr; 19(4):552-61. PubMed ID: 23253557 [TBL] [Abstract][Full Text] [Related]
38. [Clinical effect of umbilical cord blood transplantation in 37 pediatric patients with hematologic malignancies: a single-center experience]. Luan Z; Tang XF; Wu NH; Xu SX; Zhang B; Wang K; Du H Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):714-9. PubMed ID: 25008879 [TBL] [Abstract][Full Text] [Related]
39. Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes. Bradstock K; Hertzberg M; Kerridge I; Svennilson J; George B; McGurgan M; Huang G; Antonenas V; Gottlieb D Intern Med J; 2009 Nov; 39(11):744-51. PubMed ID: 19220530 [TBL] [Abstract][Full Text] [Related]
40. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience. Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]